Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169482835> ?p ?o ?g. }
- W2169482835 endingPage "1364" @default.
- W2169482835 startingPage "1358" @default.
- W2169482835 abstract "Since initial reports in April 2009, the pandemic influenza A (H1N1) virus has spread globally. Influenza vaccines are the primary method for the control of influenza and its complications. We conducted a multicenter clinical trial to evaluate the immunogenicity and safety of H1N1 vaccine (Green Cross Co.) in young adults (18 to 64 years) and the elderly (≥ 65 years) using a two-dose regimen, with the doses administered 21 days apart. Three different regimens of hemagglutinin antigen were comparatively analyzed: 3.75 μg (MF59 adjuvanted) versus 7.5 μg (MF59 adjuvanted) versus 15 μg (nonadjuvanted) in young adults and 3.75 μg (MF59 adjuvanted) versus 7.5 μg (MF59 adjuvanted) in the elderly. In young adults, all three vaccine regimens met the European Agency for the Evaluation of Medicinal Products (EMA) criteria after the first dose. In the elderly, on day 21 after the first dose, the rates of seroprotection and seroconversion were significantly higher for the 7.5-μg dose of MF59 adjuvanted vaccine than for the 3.75-μg dose (58.0% versus 44.3% [P = 0.03] and 53.7% versus 37.2% [P < 0.01], respectively). After the second dose, the geometric mean titer (GMT) increment was blunted with a 15-μg dose of nonadjuvanted vaccine, whereas the GMT increased about 2-fold with MF59 adjuvanted vaccines. In conclusion, a single 7.5-μg dose of MF59 adjuvanted vaccine would have a practical advantage over a two-dose, 3.75-μg, MF59 adjuvanted vaccine priming schedule. Following a two-dose priming schedule, the increase in hemagglutinin inhibition titers was higher with MF59 adjuvanted vaccine than with nonadjuvanted vaccine." @default.
- W2169482835 created "2016-06-24" @default.
- W2169482835 creator A5001339514 @default.
- W2169482835 creator A5009082444 @default.
- W2169482835 creator A5038612839 @default.
- W2169482835 creator A5053530849 @default.
- W2169482835 creator A5070882118 @default.
- W2169482835 creator A5072798118 @default.
- W2169482835 creator A5081947809 @default.
- W2169482835 creator A5084636217 @default.
- W2169482835 date "2011-08-01" @default.
- W2169482835 modified "2023-09-26" @default.
- W2169482835 title "Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine" @default.
- W2169482835 cites W1996101317 @default.
- W2169482835 cites W2012072069 @default.
- W2169482835 cites W2024436174 @default.
- W2169482835 cites W2024440674 @default.
- W2169482835 cites W2028326206 @default.
- W2169482835 cites W2045584501 @default.
- W2169482835 cites W2065519867 @default.
- W2169482835 cites W2068592034 @default.
- W2169482835 cites W2069185686 @default.
- W2169482835 cites W2086960440 @default.
- W2169482835 cites W2098349861 @default.
- W2169482835 cites W2110949543 @default.
- W2169482835 cites W2111299679 @default.
- W2169482835 cites W2114581239 @default.
- W2169482835 cites W2114627192 @default.
- W2169482835 cites W2123599709 @default.
- W2169482835 cites W2127662109 @default.
- W2169482835 cites W2158767298 @default.
- W2169482835 cites W2170155793 @default.
- W2169482835 doi "https://doi.org/10.1128/cvi.05111-11" @default.
- W2169482835 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3147346" @default.
- W2169482835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21715575" @default.
- W2169482835 hasPublicationYear "2011" @default.
- W2169482835 type Work @default.
- W2169482835 sameAs 2169482835 @default.
- W2169482835 citedByCount "38" @default.
- W2169482835 countsByYear W21694828352012 @default.
- W2169482835 countsByYear W21694828352013 @default.
- W2169482835 countsByYear W21694828352014 @default.
- W2169482835 countsByYear W21694828352015 @default.
- W2169482835 countsByYear W21694828352017 @default.
- W2169482835 countsByYear W21694828352018 @default.
- W2169482835 countsByYear W21694828352019 @default.
- W2169482835 countsByYear W21694828352020 @default.
- W2169482835 countsByYear W21694828352023 @default.
- W2169482835 crossrefType "journal-article" @default.
- W2169482835 hasAuthorship W2169482835A5001339514 @default.
- W2169482835 hasAuthorship W2169482835A5009082444 @default.
- W2169482835 hasAuthorship W2169482835A5038612839 @default.
- W2169482835 hasAuthorship W2169482835A5053530849 @default.
- W2169482835 hasAuthorship W2169482835A5070882118 @default.
- W2169482835 hasAuthorship W2169482835A5072798118 @default.
- W2169482835 hasAuthorship W2169482835A5081947809 @default.
- W2169482835 hasAuthorship W2169482835A5084636217 @default.
- W2169482835 hasBestOaLocation W21694828351 @default.
- W2169482835 hasConcept C126322002 @default.
- W2169482835 hasConcept C147483822 @default.
- W2169482835 hasConcept C159047783 @default.
- W2169482835 hasConcept C162156334 @default.
- W2169482835 hasConcept C203014093 @default.
- W2169482835 hasConcept C22070199 @default.
- W2169482835 hasConcept C2522874641 @default.
- W2169482835 hasConcept C2777451964 @default.
- W2169482835 hasConcept C2777546802 @default.
- W2169482835 hasConcept C2780689484 @default.
- W2169482835 hasConcept C2780868878 @default.
- W2169482835 hasConcept C2781413609 @default.
- W2169482835 hasConcept C71924100 @default.
- W2169482835 hasConceptScore W2169482835C126322002 @default.
- W2169482835 hasConceptScore W2169482835C147483822 @default.
- W2169482835 hasConceptScore W2169482835C159047783 @default.
- W2169482835 hasConceptScore W2169482835C162156334 @default.
- W2169482835 hasConceptScore W2169482835C203014093 @default.
- W2169482835 hasConceptScore W2169482835C22070199 @default.
- W2169482835 hasConceptScore W2169482835C2522874641 @default.
- W2169482835 hasConceptScore W2169482835C2777451964 @default.
- W2169482835 hasConceptScore W2169482835C2777546802 @default.
- W2169482835 hasConceptScore W2169482835C2780689484 @default.
- W2169482835 hasConceptScore W2169482835C2780868878 @default.
- W2169482835 hasConceptScore W2169482835C2781413609 @default.
- W2169482835 hasConceptScore W2169482835C71924100 @default.
- W2169482835 hasIssue "8" @default.
- W2169482835 hasLocation W21694828351 @default.
- W2169482835 hasLocation W21694828352 @default.
- W2169482835 hasLocation W21694828353 @default.
- W2169482835 hasLocation W21694828354 @default.
- W2169482835 hasOpenAccess W2169482835 @default.
- W2169482835 hasPrimaryLocation W21694828351 @default.
- W2169482835 hasRelatedWork W1965793784 @default.
- W2169482835 hasRelatedWork W1982424639 @default.
- W2169482835 hasRelatedWork W2027318795 @default.
- W2169482835 hasRelatedWork W2027457674 @default.
- W2169482835 hasRelatedWork W2046107030 @default.
- W2169482835 hasRelatedWork W2048676702 @default.
- W2169482835 hasRelatedWork W2068741835 @default.